Clinical trials
Not yet recruiting trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
56 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2023 | 1 |
| 2025 | 10 |
| 2026 | 39 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 56 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 5 |
| Bristol-Myers Squibb | 4 |
| Boehringer Ingelheim | 3 |
| National Cancer Center, Japan | 3 |
| Novo Nordisk A/S | 3 |
| Pfizer | 3 |
| GlaxoSmithKline | 2 |
| Otsuka Pharmaceutical Co., Ltd. | 2 |
| Tokyo University | 2 |
| Aesculap AG | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 6 |
| Overweight | 4 |
| Recurrence | 3 |
| Alzheimer Disease | 2 |
| Breast Neoplasms | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Dermatitis, Atopic | 2 |
| Idiopathic Pulmonary Fibrosis | 2 |
| Neoplasm Metastasis | 2 |
| Pancreatitis | 2 |
Trials
Showing 26 to 50 of 56. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.